Roch H.
- Country
- France
- Department
- Service d’hématologie
Research Overview
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-cell Lymphoma
- Phase 3 Randomized Open‑Label Study of KITE‑753 Versus Axicabtagene Ciloleucel in Relapsed or Refractory Large B‑Cell Lymphoma After First‑Line Therapy
Data & Insights
Has run more than one trial at 265 of 423 partner sites.
Specializations
B-Cell Lymphoma Research
The investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Their research includes innovative approaches using bispecific antibodies and targeted therapies.
- CAR T-cell therapies
- Novel antibody treatments
- Combination therapy approaches
A significant focus is placed on developing treatments for relapsed and refractory disease states.
T-Cell Lymphoma Studies
The investigator conducts research in peripheral T-cell lymphoma (PTCL) and its various subtypes. Their work includes evaluation of novel therapeutic combinations and transplantation strategies.
- Targeted immunotherapies
- Stem cell transplantation
- Novel drug combinations
Research encompasses both newly diagnosed and relapsed/refractory disease settings.
Emerging Therapeutics
The investigator explores cutting-edge treatments including bispecific antibodies and cellular therapies. Their research includes evaluation of novel agents such as glofitamab, epcoritamab, and mosunetuzumab.
- Immunotherapy development
- Treatment sequencing strategies
- Long-term outcomes assessment
Focus includes optimizing treatment approaches for various lymphoma subtypes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.